{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T13:30:12Z","timestamp":1791379812791,"version":"4.3.3"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2009,11,25]],"date-time":"2009-11-25T00:00:00Z","timestamp":1259107200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Virchows Arch"],"published-print":{"date-parts":[[2010,1]]},"DOI":"10.1007\/s00428-009-0860-5","type":"journal-article","created":{"date-parts":[[2009,11,24]],"date-time":"2009-11-24T06:41:08Z","timestamp":1259044868000},"page":"45-51","source":"Crossref","is-referenced-by-count":12,"title":["Tissue transglutaminase 2 as a biomarker of cervical intraepithelial neoplasia (CIN) and its relationship to p16INK4A and nuclear factor \u03baB expression"],"prefix":"10.1007","volume":"456","author":[{"given":"Ruchi","family":"Gupta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Radhika","family":"Srinivasan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raje","family":"Nijhawan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanita","family":"Suri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,11,25]]},"reference":[{"key":"860_CR1","volume-title":"GLOBOCAN 2002 cancer incidence. Mortality and prevalence worldwide","author":"J Ferlay","year":"2004","unstructured":"Ferlay J, Bray F, Pisani P et al (2004) GLOBOCAN 2002 cancer incidence. Mortality and prevalence worldwide. IARC, Lyon IARC Press Cancer Base No. 5 version 2.0"},{"key":"860_CR2","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1086\/427557","volume":"191","author":"RL Winer","year":"2005","unstructured":"Winer RL, Kiviat NB, Hughes JP et al (2005) Development and duration of human papillomavirus lesions, after initial infection. J Infect Dis 191:731\u2013738","journal-title":"J Infect Dis"},{"key":"860_CR3","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.canlet.2005.06.045","volume":"229","author":"PE Castle","year":"2005","unstructured":"Castle PE, Ashfaq R, Ansari F et al (2005) Immunohistochemical evaluation of heat shock proteins in normal and preinvasive lesions of the cervix. Cancer Lett 229:245\u2013252","journal-title":"Cancer Lett"},{"key":"860_CR4","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0014-5793(99)00018-6","volume":"446","author":"X Peng","year":"1999","unstructured":"Peng X, Zhang Y, Zhang H et al (1999) Interaction of tissue transglutaminase with nuclear transport protein importin-alpha3. FEBS Lett 446:35\u201339","journal-title":"FEBS Lett"},{"key":"860_CR5","doi-asserted-by":"crossref","first-page":"20127","DOI":"10.1074\/jbc.C200147200","volume":"277","author":"JE Boehm","year":"2002","unstructured":"Boehm JE, Singh U, Combs C et al (2002) Tissue transglutaminase protects against apoptosis by modifying the tumor suppressor protein p110. Rb J Biol Chem 277:20127\u201320130","journal-title":"Rb J Biol Chem"},{"key":"860_CR6","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1038\/sj.onc.1210035","volume":"26","author":"LS Mangala","year":"2006","unstructured":"Mangala LS, Fok JY, Zorrilla-Calancha IR et al (2006) Tissue transglutaminase expression promotes cell attachment, invasion and survival in breast cancer cells. Oncogene 26:2459\u20132470","journal-title":"Oncogene"},{"key":"860_CR7","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1158\/1535-7163.MCT-06-0083","volume":"5","author":"JY Fok","year":"2006","unstructured":"Fok JY, Ekmekcioglu S, Mehta K (2006) Implications of tissue transglutaminase expression in malignant melanoma. Mol Cancer Ther 5:1493\u20131503","journal-title":"Mol Cancer Ther"},{"key":"860_CR8","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1038\/sj.onc.1210048","volume":"26","author":"L Yuan","year":"2006","unstructured":"Yuan L, Siegel M, Choi K et al (2006) Transglutaminase 2 inhibitor, KCC009, disrupts fibronectin assembly in the extracellular matrix and sensitizes orthotopic glioblastomas to chemotherapy. Oncogene 26:2563\u20132573","journal-title":"Oncogene"},{"key":"860_CR9","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1002\/ijc.1174","volume":"92","author":"R Klaes","year":"2001","unstructured":"Klaes R, Friedrich T, Spitkovsky D et al (2001) Overexpression of p16(INK4A) as a specific marker for dysplastic and neoplastic epithelial cells of the cervix uteri. Int J Cancer 92:276\u2013284","journal-title":"Int J Cancer"},{"key":"860_CR10","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1097\/00019606-200606000-00003","volume":"15","author":"S Kang","year":"2006","unstructured":"Kang S, Kim J, Kim HB et al (2006) Methylation of p16INK4a is a non-rare event in cervical intraepithelial neoplasia. Diagn Mol Pathol 15:74\u201382","journal-title":"Diagn Mol Pathol"},{"key":"860_CR11","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1097\/00125480-200607000-00006","volume":"13","author":"AN Kalof","year":"2006","unstructured":"Kalof AN, Cooper K (2006) p16INK4a immunoexpression: surrogate marker of high-risk HPV and high-grade cervical intraepithelial neoplasia. Adv Anat Pathol 13:190\u2013194","journal-title":"Adv Anat Pathol"},{"key":"860_CR12","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1111\/j.1525-1438.2006.00355.x","volume":"16","author":"M Ishikawa","year":"2006","unstructured":"Ishikawa M, Fujii T, Saito M et al (2006) Overexpression of p16 INK4a as an indicator for human papillomavirus oncogenic activity in cervical squamous neoplasia. Int J Gynecol Cancer 16:347\u2013353","journal-title":"Int J Gynecol Cancer"},{"key":"860_CR13","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/S0046-8177(03)00284-3","volume":"34","author":"N Masumoto","year":"2003","unstructured":"Masumoto N, Fujii T, Ishikawa M et al (2003) P16 overexpression and human papillomavirus infection in small cell carcinoma of the uterine cervix. Hum Pathol 34:778\u2013783","journal-title":"Hum Pathol"},{"key":"860_CR14","doi-asserted-by":"crossref","first-page":"5273","DOI":"10.1093\/emboj\/cdg495","volume":"22","author":"JH Jeon","year":"2003","unstructured":"Jeon JH, Choi KH, Cho SY et al (2003) Transglutaminase 2 inhibits Rb binding of human papillomavirus E7 by incorporating polyamine. EMBO J 22:5273\u20135282","journal-title":"EMBO J"},{"key":"860_CR15","doi-asserted-by":"crossref","first-page":"28","DOI":"10.5483\/BMBRep.2002.35.1.028","volume":"35","author":"S Shishodia","year":"2002","unstructured":"Shishodia S, Aggarwal BB (2002) Nuclear factor-kappaB activation: a question of life or death. J Biochem Mol Biol 35:28\u201340","journal-title":"J Biochem Mol Biol"},{"key":"860_CR16","doi-asserted-by":"crossref","first-page":"8788","DOI":"10.1158\/0008-5472.CAN-06-1457","volume":"66","author":"AP Mann","year":"2006","unstructured":"Mann AP, Verma A, Sethi G et al (2006) Overexpression of tissue transglutaminase leads to constitutive activation of nuclear factor-{kappa}B in cancer cells: delineation of a novel pathway. Cancer Res 66:8788\u20138795","journal-title":"Cancer Res"},{"key":"860_CR17","doi-asserted-by":"crossref","first-page":"25576","DOI":"10.1074\/jbc.M201884200","volume":"277","author":"D Spitkovsky","year":"2002","unstructured":"Spitkovsky D, Hehner SP, Hofmann TG et al (2002) The human papillomavirus oncoprotein E7 attenuates NF-kappa B activation by targeting the Ikappa B kinase complex. J Biol Chem 277:25576\u201325582","journal-title":"J Biol Chem"},{"key":"860_CR18","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1006\/viro.2000.0363","volume":"272","author":"V Fontaine","year":"2000","unstructured":"Fontaine V, van der Meijden E, de Graaf J et al (2000) A functional NF-kappaB binding site in the human papillomavirus type 16 long control region. Virology 272:40\u201349","journal-title":"Virology"},{"key":"860_CR19","doi-asserted-by":"crossref","first-page":"3049","DOI":"10.1038\/sj.onc.1209324","volume":"25","author":"JF Herman","year":"2006","unstructured":"Herman JF, Mangala LS, Mehta K (2006) Implications of increased tissue transglutaminase (TG2) expression in drug-resistant breast cancer (MCF-7) cells. Oncogene 25:3049\u20133058","journal-title":"Oncogene"},{"key":"860_CR20","doi-asserted-by":"crossref","first-page":"10525","DOI":"10.1158\/0008-5472.CAN-06-2387","volume":"66","author":"A Verma","year":"2006","unstructured":"Verma A, Wang H, Manavathi B et al (2006) Increased expression of tissue transglutaminase in pancreatic ductal adenocarcinoma and its implications in drug resistance and metastasis. Cancer Res 66:10525\u201310533","journal-title":"Cancer Res"},{"key":"860_CR21","doi-asserted-by":"crossref","first-page":"173","DOI":"10.2741\/1789","volume":"11","author":"K Mehta","year":"2006","unstructured":"Mehta K, Fok JY, Mangala LS (2006) Tissue transglutaminase: from biological glue to cell survival cues. Front Biosci 11:173\u2013185","journal-title":"Front Biosci"},{"key":"860_CR22","first-page":"637","volume":"75","author":"JM Hettasch","year":"1996","unstructured":"Hettasch JM, Bandarenko N, Burchette JL et al (1996) Tissue transglutaminase expression in human breast cancer. Lab Invest 75:637\u2013645","journal-title":"Lab Invest"},{"key":"860_CR23","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.2741\/1863","volume":"11","author":"EA Zemskov","year":"2006","unstructured":"Zemskov EA, Janiak A, Hang J et al (2006) The role of tissue transglutaminase in cell\u2013matrix interactions. Front Biosci 11:1057\u20131076","journal-title":"Front Biosci"},{"key":"860_CR24","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1083\/jcb.148.4.825","volume":"148","author":"SS Akimov","year":"2000","unstructured":"Akimov SS, Krylov D, Fleischman LF et al (2000) Tissue transglutaminase is an integrin-binding adhesion coreceptor for fibronectin. J Cell Biol 148:825\u2013838","journal-title":"J Cell Biol"},{"key":"860_CR25","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1182\/blood.V98.5.1567","volume":"98","author":"SS Akimov","year":"2001","unstructured":"Akimov SS, Belkin AM (2001) Cell surface tissue transglutaminase is involved in adhesion and migration of monocytic cells on fibronectin. Blood 98:1567\u20131576","journal-title":"Blood"},{"key":"860_CR26","doi-asserted-by":"crossref","first-page":"2973","DOI":"10.1016\/j.yexcr.2006.05.019","volume":"312","author":"R Dardik","year":"2006","unstructured":"Dardik R, Inbal A (2006) Complex formation between tissue transglutaminase II (tTG) and vascular endothelial growth factor receptor 2 (VEGFR-2): proposed mechanism for modulation of endothelial cell response to VEGF. Exp Cell Res 312:2973\u20132982","journal-title":"Exp Cell Res"},{"key":"860_CR27","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.prp.2007.03.010","volume":"203","author":"IZ Yildiz","year":"2007","unstructured":"Yildiz IZ, Usubutun A, Firat P et al (2007) Efficiency of immunohistochemical p16 expression and HPV typing in cervical squamous intraepithelial lesion grading and review of the p16 literature. Pathol Res Pract 203:445\u2013449","journal-title":"Pathol Res Pract"},{"key":"860_CR28","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1097\/01.pgp.0000139639.79105.40","volume":"23","author":"M Branca","year":"2004","unstructured":"Branca M, Ciotti M, Santini D et al (2004) p16(INK4A) expression is related to grade of cin and high-risk human papillomavirus but does not predict virus clearance after conization or disease outcome. Int J Gynecol Pathol 23:354\u2013365","journal-title":"Int J Gynecol Pathol"},{"issue":"7","key":"860_CR29","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1097\/01.MP.0000077518.78046.0C","volume":"16","author":"SN Agoff","year":"2003","unstructured":"Agoff SN, Lin P, Morihara J et al (2003) p16(INK4a) expression correlates with degree of cervical neoplasia: a comparison with Ki-67 expression and detection of high-risk HPV types. Mod Pathol 16(7):665\u2013673","journal-title":"Mod Pathol"}],"container-title":["Virchows Archiv"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-009-0860-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00428-009-0860-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-009-0860-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T21:35:55Z","timestamp":1559079355000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00428-009-0860-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,11,25]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,1]]}},"alternative-id":["860"],"URL":"https:\/\/doi.org\/10.1007\/s00428-009-0860-5","relation":{},"ISSN":["0945-6317","1432-2307"],"issn-type":[{"value":"0945-6317","type":"print"},{"value":"1432-2307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,11,25]]}}}